A new player in the battle against RCC is coming! Oral HIF-2a inhibitor...🚨#ESMO24 ESMO - Eur. Oncology OncoAlert Dana-Farber Lank Center for Genitourinary Oncology

Exciting days !!!! Another new target for advanced RCC ESMO - Eur. Oncology

Another study with good results 💥ADRIATIC study in LS-SCLC mOS 33months to 56months (almost 2 years extension!!!) Can't wait for NICE TA to approve it to be SOC !!!! ESMO - Eur. Oncology AstraZeneca IMFINZI® (durvalumab)

POD1UM-303 has finally been revealed !!! Another positive trial outcome 💥 ESMO - Eur. Oncology Incyte @esmoGI